Category: Technology Licenses
Created On: 2022-04-28
Record Count: 12
- Alzheimerâ€™s disease
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 262864
IPSCIO Record ID: 26285
IPSCIO Record ID: 125020
IPSCIO Record ID: 266151
IPSCIO Record ID: 291176
License shall mean the exclusive worldwide license to practice the Research Technology (as hereinafter defined) for the development, manufacture, use and sale of the Licensed Products (as hereinafter defined) in the Field.
University Patents shall mean all United States and foreign patents and patent applications, and any divisions, continuations, in whole or in part, reissues, renewals and extensions thereof, and pending applications therefor
which claim Pre-Existing Inventions and which are identified on hereto; or
which claim inventions that are made, in whole or in part, by students or employees of University during the term and in the course of the University Research Project.
6,713,450 – Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid .beta. for induction of an immune response to amyloid .beta. and amyloid deposits
University Research Project shall mean the investigations at University during the Research Period (as hereinafter defined) into the Field under the supervision of the University Scientist(s) in accordance with the research program, which forms an integral part hereof.
Research Technology shall mean all University Patents and University Know-How.
IPSCIO Record ID: 362534
For the Grant of License, Licensor grants, commencing immediately upon exercise of the Option and for the term of this Agreement, a non-exclusive license under the Licensed Patents, with the right to grant sublicenses, to develop, have developed, make, have made, use, offer to sell, sell, import and have imported Licensed Products in the Territory in the Field.
Lead Compound means Licensees antibody directed toward Amyloid Beta, commonly referred to within Licensee xx-04360365
Licensed Product means any product in any dosage form containing the licensed Pfizer Compound, the development, manufacture, use, sale or importation of which product would, absent the license granted by Licensor to Licensee herein, infringe any Valid Claim in any Licensed Patent.
Pfizer Compound means any antibody owned or licensed by Licensee or an Affiliate directed towards Amyloid Beta, including the Lead Compound.
IPSCIO Record ID: 362501
For the Grant of License. when Licensee exercises the option, Licensor grants, commencing immediately upon exercise of the Option and for the term of this Agreement, a non-exclusive, license under the Licensed Patents, with the right to grant sublicenses, to develop, have developed, make, have made, use, offer to sell, sell, import and have imported Licensed Products in the Territory in the Field.
Licensees Compound means any compound, including but not limited to an antibody directed towards Beta Amyloid.
Licensed Product means any product in any dosage form, the development, manufacture, use, sale or importation of which product would, absent the grant by Licensor to Licensee of the license described herein, infringe any Valid Claim in any Licensed Patent. To avoid any doubt, Licensed Product shall include, without limitation, the Licensees Antibody currently under development for treatment of Alzheimers disease, designated x-933776A
IPSCIO Record ID: 29371
IPSCIO Record ID: 27552
This Agreement initially contemplates a transfer of existing Alzheimer Therapeutic Know-how to Licensee. Pursuant to such initial transfer and continuing collaboration thereafter, it is contemplated that Licensee will determine the amino add sequence of proteins and base sequence of nucleic acids, generate monoclonal antibodies, done and express and assess biological and therapeutic activity of proteins, all related to the Field of this Agreement.
In addition, Licensee will engage in a collaborative research project directed to the Field and funded by Licensee, which collaboration is contemplated to include
a. development by Licensee of therapeutics based on specific materials provided; and
b. other related research and development related to the development by Licensee of therapeutics for Alzheimer's disease.
IPSCIO Record ID: 274655
IPSCIO Record ID: 3499
Also as part of the agreement, the companies will initiate a research collaboration focused on optimizing early stage antibodies targeting alpha-synuclein including incorporation of licensee's proprietary Brain Shuttleâ„¢ technology to increase delivery of therapeutic antibodies to the brain.
Synuclein proteins are a family of charged proteins found throughout the body. One protein from this family, alpha-synuclein, is found extensively in neurons and is a major component of pathological inclusions that characterize several neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, neurodegeneration with brain iron accumulation type 1, and multiple system atrophy, which collectively are termed synucleinopathies.
IPSCIO Record ID: 203273
Licensor hereby grants each Licensee a non-exclusive license, with the right to grant sublicenses, under the Licensed Patents to research, develop, use, have used, make, have made, offer for sale, sell, have sold, import and export Licensed Products other than Bapineuzumab Products in the Field in the Territory.
The patents relate to DNA Encoding Recombinant Antibody Molecules End Specific for Amyloid ÃŸ Peptide.
AÃŸ Peptide shall mean P-amyloid protein which is the cleavage product of amyloid precursor protein, occurring predominantly as a (1-39) to (1-43) amino acid.